US Stock MarketDetailed Quotes

BBLGW BONE BIOLOGICS CORP C/WTS (TO PUR COM)

Watchlist
  • 60.5000
  • 0.00000.00%
Close Jul 23 10:11 ET
0Market Cap0.00P/E (TTM)

BONE BIOLOGICS CORP C/WTS (TO PUR COM) Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
75.34%-895.87K
3.45%-1.3M
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
-42.30%-395.28K
Net income from continuing operations
55.70%-783.73K
76.66%-865.97K
-502.76%-8.95M
-273.47%-1.55M
-57.45%-1.92M
-276.99%-1.77M
-438.06%-3.71M
7.83%-1.48M
602.69%893.46K
-139.40%-1.22M
Operating gains losses
99.15%-10.79K
-106.63%-37.31K
69.35%-892.69K
---24.76K
---160.65K
---1.27M
--562.92K
---2.91M
----
----
Other non cash items
----
----
----
----
----
----
---1
47.66%731.71K
----
----
Change In working capital
80.52%-118.79K
-125.84%-452.81K
178.94%132.92K
29.15%-514.51K
-162.53%-494.89K
-773.99%-609.9K
640.60%1.75M
47.46%-168.37K
-1,023.30%-726.21K
1,749.54%791.46K
-Change in prepaid assets
-1,159.62%-249.46K
-72.54%99.25K
125.68%245.73K
77.01%-187.44K
46.08%91.48K
-126.49%-19.8K
229.51%361.49K
---956.93K
-1,763.01%-815.19K
227.76%62.63K
-Change in payables and accrued expense
-87.12%85.69K
-1,426.51%-552.07K
13,655.69%670.87K
165.73%456.61K
-167.59%-492.62K
4,131.15%665.26K
192.49%41.62K
101.33%4.88K
-2,444.23%-694.69K
5,320.16%728.84K
-Change in other working capital
----
----
-200.00%-783.68K
----
----
---1.26M
--1.35M
1,641.50%783.68K
----
----
Cash from discontinued investing activities
Operating cash flow
75.34%-895.87K
3.45%-1.3M
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
-42.30%-395.28K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-99.99%299
1.5M
13.87%5.04M
-86.64%592K
0
4.45M
0
-43.95%4.43M
-35.41%4.43M
0
Net common stock issuance
-100.00%-137
--1.5M
13.87%5.04M
-86.64%592K
--0
--4.45M
--0
-35.41%4.43M
--4.43M
--0
Cash from discontinued financing activities
Financing cash flow
-99.99%299
--1.5M
13.87%5.04M
-86.64%592K
--0
--4.45M
--0
-43.95%4.43M
-35.41%4.43M
--0
Net cash flow
Beginning cash position
-47.84%3.23M
-59.85%3.03M
12.93%7.54M
-11.99%4.45M
28.48%7.01M
6.43%6.19M
12.93%7.54M
--6.68M
149,847.93%5.06M
122,804.96%5.45M
Current changes in cash
-209.28%-895.57K
114.89%201.07K
-622.83%-4.51M
-157.52%-1.43M
-546.44%-2.56M
327.60%819.49K
-56.83%-1.35M
-87.07%862.95K
-62.84%2.48M
-37,050.28%-395.28K
End cash Position
-66.72%2.33M
-47.84%3.23M
-59.85%3.03M
-59.85%3.03M
-11.99%4.45M
28.48%7.01M
6.43%6.19M
12.93%7.54M
12.93%7.54M
149,847.93%5.06M
Free cash flow
75.34%-895.87K
3.45%-1.3M
-167.90%-9.56M
-3.45%-2.02M
-546.44%-2.56M
-908.90%-3.63M
-56.83%-1.35M
-190.33%-3.57M
-944.03%-1.95M
-42.30%-395.28K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 75.34%-895.87K3.45%-1.3M-167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M-42.30%-395.28K
Net income from continuing operations 55.70%-783.73K76.66%-865.97K-502.76%-8.95M-273.47%-1.55M-57.45%-1.92M-276.99%-1.77M-438.06%-3.71M7.83%-1.48M602.69%893.46K-139.40%-1.22M
Operating gains losses 99.15%-10.79K-106.63%-37.31K69.35%-892.69K---24.76K---160.65K---1.27M--562.92K---2.91M--------
Other non cash items ---------------------------147.66%731.71K--------
Change In working capital 80.52%-118.79K-125.84%-452.81K178.94%132.92K29.15%-514.51K-162.53%-494.89K-773.99%-609.9K640.60%1.75M47.46%-168.37K-1,023.30%-726.21K1,749.54%791.46K
-Change in prepaid assets -1,159.62%-249.46K-72.54%99.25K125.68%245.73K77.01%-187.44K46.08%91.48K-126.49%-19.8K229.51%361.49K---956.93K-1,763.01%-815.19K227.76%62.63K
-Change in payables and accrued expense -87.12%85.69K-1,426.51%-552.07K13,655.69%670.87K165.73%456.61K-167.59%-492.62K4,131.15%665.26K192.49%41.62K101.33%4.88K-2,444.23%-694.69K5,320.16%728.84K
-Change in other working capital ---------200.00%-783.68K-----------1.26M--1.35M1,641.50%783.68K--------
Cash from discontinued investing activities
Operating cash flow 75.34%-895.87K3.45%-1.3M-167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M-42.30%-395.28K
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -99.99%2991.5M13.87%5.04M-86.64%592K04.45M0-43.95%4.43M-35.41%4.43M0
Net common stock issuance -100.00%-137--1.5M13.87%5.04M-86.64%592K--0--4.45M--0-35.41%4.43M--4.43M--0
Cash from discontinued financing activities
Financing cash flow -99.99%299--1.5M13.87%5.04M-86.64%592K--0--4.45M--0-43.95%4.43M-35.41%4.43M--0
Net cash flow
Beginning cash position -47.84%3.23M-59.85%3.03M12.93%7.54M-11.99%4.45M28.48%7.01M6.43%6.19M12.93%7.54M--6.68M149,847.93%5.06M122,804.96%5.45M
Current changes in cash -209.28%-895.57K114.89%201.07K-622.83%-4.51M-157.52%-1.43M-546.44%-2.56M327.60%819.49K-56.83%-1.35M-87.07%862.95K-62.84%2.48M-37,050.28%-395.28K
End cash Position -66.72%2.33M-47.84%3.23M-59.85%3.03M-59.85%3.03M-11.99%4.45M28.48%7.01M6.43%6.19M12.93%7.54M12.93%7.54M149,847.93%5.06M
Free cash flow 75.34%-895.87K3.45%-1.3M-167.90%-9.56M-3.45%-2.02M-546.44%-2.56M-908.90%-3.63M-56.83%-1.35M-190.33%-3.57M-944.03%-1.95M-42.30%-395.28K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg